A Comparison of Stem Cells for Therapeutic Use

Rodgerson, Denis; Harris, Alan
December 2011
Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782
Academic Journal
A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent that two sources currently exist for non-embryonic pluripotent stem cells-very small embryonic-like stem cells (VSELs) and induced pluripotent stem cells (iPS). The impact of the emerging iPS research on therapy is considered.


Related Articles

  • Keeping an eye on stem cells for studying disease modelling and cell-based therapy. Crombie, Duncan // Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19 

    The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research...

  • Stemming Our Irrational Exuberance. Brenner, Malcolm K. // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1399 

    The author reflects on the technique to generate human embryonic stem cells (hESCs) and inducible pluripotent stem cells (iPSCs). He says that hESCs and iPSCs are genetically modified and has a major benefit for almost every disease. An overview of the argument regarding the bond issue for the...

  • Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Hwang, Eun // Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207 

    Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However,...

  • Personalized Regenerative Medicine. Arjmand, Babak; Goodarzi, Parisa; Mohamadi-Jahani, Fereshteh; Falahzadeh, Khadijeh; Larijani, Bagher // Acta Medica Iranica;2017, Vol. 55 Issue 3, p144 

    Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms precision and personalized medicines are sometimes...

  • The promise of induced pluripotent stem cells in research and therapy. Robinton, Daisy A.; Daley, George Q. // Nature;1/19/2012, Vol. 481 Issue 7381, p295 

    The field of stem-cell biology has been catapulted forward by the startling development of reprogramming technology. The ability to restore pluripotency to somatic cells through the ectopic co-expression of reprogramming factors has created powerful new opportunities for modelling human diseases...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Wakeman, Dustin R.; Xie, Zhong; Carrillo-Reid, Luis; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Yang, Lichuan; Beal, M. Flint; Surmeier, D. James; Kordower, Jeffrey H.; Tabar, Viviane; Studer, Lorenz // Nature;12/22/2011, Vol. 480 Issue 7378, p547 

    Human pluripotent stem cells (PSCs) are a promising source of cells for applications in regenerative medicine. Directed differentiation of PSCs into specialized cells such as spinal motoneurons or midbrain dopamine (DA) neurons has been achieved. However, the effective use of PSCs for cell...

  • Amniotic fluid stem cells: an ideal resource for therapeutic application in bone tissue engineering. PANTALONE, A.; ANTONUCCI, I.; GUELFI, M.; PANTALONE, P.; USUELLI, F. G.; STUPPIA, L.; SALINI, V. // European Review for Medical & Pharmacological Sciences;Jul2016, Vol. 20 Issue 13, p2884 

    OBJECTIVE: Skeletal diseases, both degenerative and secondary to trauma, infections or tumors, represent an ideal target for regenerative medicine and in the last years, stem cells have been considered as good candidates for in vitro and in vivo bone regeneration. To date, several stem cell...

  • Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cao, Nan; Liang, He; Huang, Jijun; Wang, Jia; Chen, Yixiong; Chen, Zhongyan; Yang, Huang-Tian // Cell Research;Sep2013, Vol. 23 Issue 9, p1119 

    Cardiovascular progenitor cells (CVPCs) derived from human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), hold great promise for the study of cardiovascular development and cell-based therapy of heart diseases, but...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics